RSCF

Reflect Scientific, Inc. RSCF

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RSCF CBSC LIFD IDXG RNVA TDSGF RVVTF CTABF ENZN FNAM
6M -9.09 % -50.00 % -26.32 % 52.11 % 9 900.00 % -12.96 % -45.45 % 0.00 % -52.83 % 0.00 %
YTD 4.17 % -64.29 % -42.86 % -59.25 % 9 900.00 % -42.05 % 73.08 % 0.00 % -77.78 % -75.00 %
1Y 13.64 % -61.36 % -42.86 % -61.43 % 9 900.00 % -37.25 % 47.54 % 0.00 % -81.82 % -75.00 %
3Y -21.81 % -87.41 % -87.27 % 63.64 % 100.00 % -80.78 % -91.00 % -98.89 % -84.31 % -99.97 %
5Y -89.36 % -98.08 % -93.07 % -69.14 % -100.00 % -83.90 % -98.32 % -99.99 % -83.83 % -99.98 %
10Y 4.17 % -98.15 % -62.67 % -97.60 % -87.50 % -83.90 % -97.94 % -100.00 % -95.32 % -99.99 %
From the beginning -95.37 % -98.15 % -92.53 % -99.95 % -99.99 % -83.90 % -98.29 % -100.00 % -97.10 % -100.00 %

Dividend

Enzon Pharmaceuticals, Inc.